A. Altman

发表

Vulvar postoperative care, gestalt or evidence based medicine? A comprehensive systematic review.

A. Altman, C. Robinson, 2017, Gynecologic oncology.

Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.

A. Gavin, J. Ferlay, F. Bray, 2020, Gynecologic oncology.

Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.

M. Köbel, B. Clarke, J. McAlpine, 2015, Gynecologic oncology.

Understanding the Experience of Canadian Women Living with Ovarian Cancer through the Every Woman StudyTM

A. Tone, A. Altman, F. Reid, 2022, Current oncology.

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations.

B. Rau, M. Pocard, O. Sgarbura, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Guidelines for Vulvar and Vaginal Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.

J. Sehouli, S. Dowdy, A. Altman, 2020, American journal of obstetrics and gynecology.

Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival

M. Nachtigal, A. Altman, E. Dean, 2016, Obstetrics and gynecology.

Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer

G. Hanna, R. Kimmig, A. Mariani, 2021, International Journal of Gynecological Cancer.

Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations—2019 update

O. Ljungqvist, C. Gillis, J. Nygren, 2019, International Journal of Gynecological Cancer.

Examining the Selection Criteria of Neoadjuvant Chemotherapy Patients.

M. Nachtigal, D. Turner, A. Altman, 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

The Effects of Anemia and Blood Transfusion on Patients With Stage III-IV Ovarian Cancer

P. Ghatage, Xiao-qing Liu, A. Altman, 2013, International Journal of Gynecologic Cancer.

Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study

B. Rosen, J. McGee, Wei Xu, 2018, International Journal of Gynecologic Cancer.

Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery.

P. Ghatage, A. Altman, G. Nelson, 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

J. Bentley, A. Altman, S. Murray, 2008, Obstetrics and gynecology.

Pfannenstiel incision closure: a review of current skin closure techniques.

V. Allen, A. Altman, S. McNeil, 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer

M. Nachtigal, F. Schweizer, A. Altman, 2022, Cancers.

Diagnostic and referral intervals for Manitoba women with epithelial ovarian cancer - the Manitoba Ovarian Cancer Outcomes (MOCO) study group: a retrospective cross-sectional study.

M. Nachtigal, D. Turner, A. Altman, 2017, CMAJ open.

A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers

A. Tinker, A. Oza, D. Provencher, 2022, Current oncology.

Low-Risk Gestational Trophoblastic Neoplasia in Manitoba: Experience With Alternating Methotrexate and Dactinomycin

A. Altman, E. Dean, R. Lotocki, 2018, International Journal of Gynecologic Cancer.

Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care

J. Kwon, N. Hacker, G. Kristensen, 2020, International Journal of Gynecological Cancer.

Uterine Sarcoma and Aromatase Inhibitors: Tom Baker Cancer Centre Experience and Review of the Literature

P. Ghatage, A. Altman, G. Nelson, 2012, International Journal of Gynecologic Cancer.

Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery.

A. Altman, F. Schwenter, M. Carrier, 2019, American journal of surgery.

Canadian Enhanced Recovery After Surgery (ERAS) Cesarean Delivery Perioperative Management Survey.

A. Altman, A. Metcalfe, R. Douglas Wilson, 2021, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Enhanced recovery after surgery: implementing a new standard of surgical care

J. McGee, V. Samouëlian, A. Altman, 2019, Canadian Medical Association Journal.

Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case report.

P. Tsang, R. Schellenberg, L. Arbour, 2006, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

New approaches to cancer care in a COVID-19 world

M. Achiam, J. Kwon, A. Spigelman, 2020, The Lancet Oncology.

Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study.

G. Pond, J. Kwon, L. Elit, 2021, Gynecologic oncology.

Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019

K. McManus, M. Nachtigal, K. Decker, 2022, Current oncology.

Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II

O. Ljungqvist, C. Achtari, P. Ramirez, 2016, Gynecologic oncology.

Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo

M. Nachtigal, F. Schweizer, A. Altman, 2021, Translational oncology.

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.

B. Rau, M. Pocard, O. Sgarbura, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pure Immature Teratoma of the Ovary in Adults

A. Altman, C. Robinson, E. Dean, 2015, International Journal of Gynecologic Cancer.

Rate of Appendiceal Metastasis with Non-Serous Epithelial Ovarian Cancer in Manitoba.

M. Nachtigal, A. Altman, E. Dean, 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors

M. Köbel, S. Kalloger, D. Capper, 2013, Modern Pathology.

No 385 - Indications de l'examen pelvien.

Amanda Loewy, A. Altman, Devon Evans, 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

No. 385-Indications for Pelvic Examination.

Amanda Loewy, A. Altman, Devon Evans, 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status Phase II LIGHT study primary analysis

D. Provencher, C. Aghajanian, K. Cadoo, 2022, Gynecologic oncology.

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap

W. Meschino, H. Hirte, M. Bernardini, 2018, Journal of Medical Genetics.

International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery.

O. Ljungqvist, J. McGee, C. Achtari, 2019, American journal of obstetrics and gynecology.

The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples

K. McManus, M. Nachtigal, A. Altman, 2017, PLoS genetics.

Guidelines for pre-and intraoperative care in gynecologic / oncology surgery : Enhanced Recovery After Surgery ( ERAS ® ) Society recommendations — Part

O. Ljungqvist, C. Achtari, P. Ramirez, 2015 .

The Canadian Gynecologic Oncology Peri-operative Management Survey: re-examining Enhanced Recovery After Surgery (ERAS) recommendations

A. Altman, A. Rozenholc, G. Nelson, 2022, International Journal of Gynecological Cancer.

Spontaneous Rupture of an Unscarred Uterus Diagnosed Postpartum: A Case Report.

A. Altman, Olga Haakman, Devon Ambrose, 2015, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Gynecologic/Oncology Surgery

P. Ramirez, S. Dowdy, J. Bakkum-Gamez, 2020 .

The Risk of Postoperative Infectious Complications Following Massive Intraoperative Blood Loss During Gynaecologic Laparotomy: Retrospective Cohort Study.

A. Altman, E. Dean, V. Poliquin, 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.

P. Ghatage, A. Altman, G. Nelson, 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group

M. Nachtigal, D. Turner, A. Altman, 2017, International Journal of Gynecologic Cancer.

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification

A. Talhouk, S. Leung, A. Tinker, 2022, Modern Pathology.

Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk‐reducing surgical decision‐making practices: A mixed‐methods study

K. McManus, J. N. Hartley, M. Nachtigal, 2023, Journal of genetic counseling.

Malignant transformation of mature cystic teratoma of the ovary: 30-year experience of a single tertiary care center.

A. Altman, C. Robinson, E. Dean, 2016, European journal of gynaecological oncology.

Luteinized Thecomas ("Thecomatosis") with Sclerosing Peritonitis (LTSP): Report of 2 Cases and Review of an Enigmatic Syndrome Associated with a Peritoneal Proliferation of Specialized (vimentin+/keratin+/CD34+) Submesothelial Fibroblasts.

J. Bentley, A. Altman, S. Murray, 2016, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Vacuum assisted wound closures in gynaecologic surgery.

P. Ghatage, A. Altman, G. Nelson, 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Impact of Nutrition on Enhanced Recovery After Surgery (ERAS) in Gynecologic Oncology

A. Altman, G. Nelson, S. Bisch, 2019, Nutrients.

A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer

A. Tinker, N. Dhani, P. Ghatage, 2023, Therapeutic advances in medical oncology.

Postoperative Infection in the Setting of Massive Intraoperative Blood Loss.

A. Altman, E. Dean, V. Poliquin, 2016, Journal of Obstetrics and Gynaecology Canada.

Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study

A. Gavin, J. Ferlay, F. Bray, 2022, International journal of cancer.

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.

C. Fotopoulou, J. Bakkum-Gamez, G. Glaser, 2023, Gynecologic oncology.

Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study.

B. Rosen, J. McGee, Wei Xu, 2017, Gynecologic oncology.

Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study

G. Pond, J. Kwon, L. Elit, 2023, Current oncology.

Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin

A. Altman, Sarah Kean, B. Hosseini, 2017, Gynecologic Oncology Reports.

Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma

M. Köbel, S. Kalloger, P. Ghatage, 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples.

K. McManus, M. Nachtigal, A. Altman, 2021, Gynecologic oncology.

A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma

A. Altman, A. Ong, P. Lambert, 2021, International Journal of Gynecological Cancer.

Time to surgery and the risk of cancer progression in patients with gynaecologic cancers of the lower genital tract.

A. Altman, G. Nelson, Brett Vair, 2015, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Extra-uterine endometrial stromal sarcoma of the left adnexa and distal ureter: A case report

A. Altman, N. Azordegan, L. Roberts, 2021, Gynecologic oncology reports.

M. Köbel, B. Clarke, J. McAlpine, 2016, Gynecologic oncology.

Olaparib treatment (Tx) in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Overall survival (OS) results from the phase II LIGHT study.

D. Provencher, C. Aghajanian, K. Cadoo, 2021 .

Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I.

O. Ljungqvist, C. Achtari, P. Ramirez, 2016, Gynecologic oncology.

A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer

A. Tinker, N. Dhani, P. Ghatage, 2023, Therapeutic advances in medical oncology.

Tubal teratoma causing anti-NMDAR encephalitis.

A. Altman, Laura Power, J. James, 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma

A. Altman, A. Ong, P. Lambert, 2022, International Journal of Gynecological Cancer.

Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer.

M. Nachtigal, A. Altman, C. Robinson, 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Ovarian cancer in Manitoba: trends in incidence and survival, 1992-2011.

M. Nachtigal, D. Turner, A. Altman, 2017, Current oncology.

Ovarian Cancer in the Older Manitoban Population—Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study

M. Nachtigal, A. Altman, Erin Dean, 2024, Current Oncology.

The Canadian Gynaecologic Oncology Perioperative Management Survey: Baseline Practice Prior to Implementation of Enhanced Recovery After Surgery (ERAS) Society Guidelines.

A. Altman, G. Nelson, 2016, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.